Journal
LEUKEMIA RESEARCH
Volume 30, Issue 1, Pages 103-105Publisher
PERGAMON-ELSEVIER SCIENCE LTD
DOI: 10.1016/j.leukres.2005.05.008
Keywords
ATL; alemtuzumab; pentostatin; HTLV-I
Categories
Ask authors/readers for more resources
lreatment of adult T-cell leukemia (ATL) remains difficult. Aletntuzumab with or without nucleoside analogs such as pentostatin may provide a role in this setting. However, the associated immunosuppression is a concern in patients with viral-mediated disease. (c) 2005 Elsevier Ltd. All rights reserved.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available
Share Paper
